sodium 2,2 dimethylbutyrate

DRUG2 trials

Sponsors

Boston University

Conditions

Beta Thalassemia Intermedia

Phase 2

Study of SDMB (2,2 Dimethylbutyrate, Sodium Salt) in Beta Thalassemia Intermedia in Thailand

CompletedNCT01609595

Boston UniversityBeta Thalassemia Intermedia

Start: 2012-03-31End: 2012-12-31Updated: 2013-03-13

Trial of HQK-1001 in Beta Thalassemia Intermedia in Lebanon

CompletedNCT01642758

Boston UniversityBeta Thalassemia Intermedia

Start: 2012-05-31End: 2013-01-31Updated: 2013-03-14

Related Papers

A Phase 2 Trial Of The Fetal Hemoglobin Inducer HQK-1001 (2,2-dimethylbutyrate, Sodium Salt) In Non-Transfusion-Dependent β-Thalassemia

Blood2013-11-15